#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Myelin oligodendrocyte glycoprotein antibody-associated disease Brain abscess Chronic hepatitis B Glioma Retinal artery occlusion IPEX syndrome Scedosporium infection Amyotrophic lateral sclerosis gene carrier B-cell type acute leukaemia Chronic lymphocytic leukaemia Biotinidase deficiency Superficial vein thrombosis Krabbe's disease Anti-neutrophil cytoplasmic antibody positive vasculitis Erythema More trials…

    Learn about Rare Diseases

    Netherton’s syndrome Medulloblastoma – Treatment Mucopolysaccharidosis I Antisynthetase syndrome Osteosarcoma – Trials in Disease Bronchiolitis obliterans syndrome – Trials in Disease Shprintzen-Goldberg syndrome – Basic Information Biotinidase deficiency – Trials in Disease Nephroblastoma – Life with Disease Antisynthetase syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Hyoscine Butylbromide 6QC-ICG Salbutamol Sulfate Ph. Eur. Decitabine Rtp-026 Sodium Emraclidine Damoctocog Alfa Pegol Triamcinolone Ptg-Carcik-Cd19 Anastrozole Asciminib INDAPAMIDE HEMIHYDRATE PRT3789 Oxaliplatin Hydrocortisone Iberdomide TETRODOTOXIN Lutropin Alfa Pralsetinib Fluciclovine (18F) More therapies…

    Learn about Your Condition

    Rhabdoid tumour Medulloblastoma Intracranial aneurysm Systemic candida Epithelioid sarcoma Febrile neutropenia Ewing's sarcoma Drug dependence Small for dates baby Breast cancer female Type 2 diabetes mellitus Pigmentary glaucoma Colon cancer stage III Benign neoplasm of ureter Cholangitis sclerosing More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Bacterial Infections and Mycoses

  • Study on Short vs. Standard Amoxicillin Treatment for Adults with Lower Limb Erysipelas

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pyoderma
    Investigated Drugs:
    • Amoxicillin Sodium
    France

  • Study on the Effectiveness and Safety of Metronidazole, Neomycin Sulfate, and Nystatin for Women with Bacterial Vaginosis and Yeast Infections

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Bacterial vaginosis
    • Vulvovaginal candidiasis
    Investigated Drugs:
    • Neomycin Sulfate
    • Nystatin
    • Metronidazole
    Romania

  • Study on Posaconazole for Treating Fungal Infections in Children Under 2 Years

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Fungal infection
    Investigated Drugs:
    • Posaconazole
    Belgium Greece Poland

  • Study on Inhaled Levofloxacin for Treating Community-Acquired Pneumonia in Patients Without Systemic Antibiotics

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    • Levofloxacin
    • Piperacillin
    • Tazobactam
    Denmark

  • Study on Cefiderocol for Treating Gram-negative Bacterial Infections in Hospitalized Infants Under 3 Months

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Bacterial infection
    Investigated Drugs:
    • Cefiderocol
    Bulgaria Greece Spain

  • Study on the Safety and Tolerability of Higher Dose Rifampicin for Tuberculosis Patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    • Rifampicin
    Denmark Italy The Netherlands
Previous Page
1 … 28 29 30 31 32 … 46
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!